Home
About
Overview
Sharing Data
ORCID
Help
History (16)
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting.
Principal Investigator
Should palonosetron be a preferred 5-HT3 receptor antagonist for chemotherapy-induced nausea and vomiting? An updated systematic review and meta-analysis.
NF-?B, Mesenchymal Differentiation and Glioblastoma.
Neuraxial Anesthesia and the Ubiquitous Platelet Count Question-How Low Is Too Low?
See All 16 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Demonbreun, Alexis
One or more keywords matched the following items that are connected to
Demonbreun, Alexis
Item Type
Name
Concept
Mice, Inbred DBA
Academic Article
Genetic background influences muscular dystrophy.
Academic Article
Intermittent glucocorticoid steroid dosing enhances muscle repair without eliciting muscle atrophy.
Academic Article
Genetic modifiers of muscular dystrophy act on sarcolemmal resealing and recovery from injury.
Academic Article
Dusp6 is a genetic modifier of growth through enhanced ERK activity.
Academic Article
"Of Mice and Measures": A Project to Improve How We Advance Duchenne Muscular Dystrophy Therapies to the Clinic.
Academic Article
The super-healing MRL strain promotes muscle growth in muscular dystrophy through a regenerative extracellular matrix.
Search Criteria
Mice Inbred DBA